Dr. Van Wert is a co-founder and CEO of Vynca. In addition to his role at Vynca, Dr. Van Wert is a part-time Clinical Assistant Professor at Stanford University, where he maintains a small clinical practice. Prior to Vynca, Dr. Van Wert co-founded AWAIR, Inc., a medical device company focused on reducing complications for critically ill patients, which was acquired by Cook Medical Technologies in 2015. He is frequently invited to speak about his passion for improving care delivery at the end of life and the process of value-driven healthcare innovation. He is a named inventor on multiple issued and pending health technology patents.

Dr. Van Wert graduated with the University Medal in chemical engineering from Queen’s University, Canada. He completed medical school internal medicine residency at the University of Toronto, and his post-doctoral training at Stanford University in Pulmonary Disease, Critical Care Medicine and Biodesign. He holds three board certifications from the American Board of Internal Medicine and is a fellow of the Royal College of Physicians of Canada.

Jack brings more than 20 years of experience in application design and implementation. Prior to joining Vynca, Jack led teams in IT and engineering functions at Capgemini, Cisco, Southern California Edison, CCC, Groundhog Technologies, and his own start-up. He has architected and implemented products that have been used by fortunate 500 companies, and specializes in production integration and big data calculation.

Jack has bachelors and masters in Biomedical Engineering from University of Southern California.

Rob brings more than 15 years of experience building and growing web and mobile solutions for the acute and post-acute user. Rob used his knowledge and expertise in product management, pragmatic marketing, agile development, and IT and UX/UI design to build out multiple products with American Hospital Association, Accretive Health, Aetna, and Allscripts. At Vynca, he builds with an eye on the strategic future while accomplishing early wins for clients.

Rob holds a Bachelors in Sociology from Iowa State University, a Masters in Information Systems Management from Keller Graduate School, and is Pragmatic Marketing Certified, Level VI.

Andrew brings several years of healthcare experience across value-based care, revenue cycle management strategy, and patient predictive analytics. Prior to joining Vynca, Andrew was a vice president at Remedy Partners, an innovative company that enabled healthcare organizations to shift to alternative payment models. At Remedy, Andrew led teams responsible for connecting providers, payers, and patients to create value-based care arrangements, centering the patient’s experience around an episode of care.

Andrew holds an MBA from the University of Michigan, Stephen M. Ross School of Business, as well as a bachelor’s degree in economics from Grand Valley State University.

Dr. Van Wert is a co-founder and CEO of Vynca. In addition to his role at Vynca, Dr. Van Wert is a part-time Clinical Assistant Professor at Stanford University, where he maintains a small clinical practice. Prior to Vynca, Dr. Van Wert co-founded AWAIR, Inc., a medical device company focused on reducing complications for critically ill patients, which was acquired by Cook Medical Technologies in 2015. He is frequently invited to speak about his passion for improving care delivery at the end of life and the process of value-driven healthcare innovation. He is a named inventor on multiple issued and pending health technology patents.

Dr. Van Wert graduated with the University Medal in chemical engineering from Queen’s University, Canada. He completed medical school internal medicine residency at the University of Toronto, and his post-doctoral training at Stanford University in Pulmonary Disease, Critical Care Medicine and Biodesign. He holds three board certifications from the American Board of Internal Medicine and is a fellow of the Royal College of Physicians of Canada.

Rush is an experienced early stage medical technology entrepreneur who has previously founded three healthcare technology companies. He has a wide breath of early stage startup experience in operations, product management, business development, and as an early stage CEO. Rush is also an accomplished inventor with 9 issued patents and over 30 pending patent applications in the fields of medical devices, pharmaceuticals, and healthcare IT.

Rush received his bachelor’s degree in Chemical Engineering from the University of Texas at Austin, his MBA from Indiana University, and his PhD in Biomedical Engineering from Purdue University. He completed Post-Doctorate studies at Stanford University in the Biodesign Fellowship and is regularly invited to teach their Innovation Process to R&D teams at major medical technology companies.

Arnie E. Burchianti, II is the Founder and Chief Executive Officer of Celtic Healthcare, Inc. and served as the founding CEO of Graham Healthcare Group, a leading post-acute, hospice and home healthcare provider in Pennsylvania, Illinois, and Michigan. He has served in this leadership capacity from 1996 through March of 2018 and has led the company through a significant period of growth by utilizing technology to improve the efficiency and cost effectiveness of business processes and workflows.

Burchianti has led Celtic Healthcare to being honored numerous times throughout the past decade as “Fastest Growing Life Sciences Company,” “Best Place to Work in Pittsburgh,” “Top 50 Best Places to Work in Western PA,” and “Top 100 Best Places to Work in PA.”

In September 2012, Graham Holdings Company (formerly The Washington Post Company) acquired a majority interest in Celtic Healthcare with Burchianti continuing to run the business as CEO and co-owner. This strategic transaction has positioned Celtic Healthcare for continued growth by combining Celtic’s strong leadership, technology and expertise with the financial resources and long-term investment commitment of The Washington Post Company.

In 2015, Burchianti spearheaded Celtic Healthcare’s strategic joint venture with Highmark Health’s Allegheny Health Network Home Health & Hospice. While simultaneously, securing PA Certification for Celtic’s software analytics tool for Home Health Utilization Management.

In July 2016, Celtic merged with Residential Home Health and Hospice to form Graham Healthcare Group, and Burchianti assumed the role of Chief Executive Officer over the combined company, which doubled in size and revenue.

Education & Special Recognitions:

• Master’s Degree in Physical Therapy & Bachelors Degree in Health Science, Duquesne University, 1994
• Ernst & Young “Entrepreneur of the Year” 2014 and two-time Ernst & Young “Entrepreneur of the Year” Finalist, 2002, 2007
• Pacesetters Award Finalist for Emerging Business, 2007
• Pittsburgh Technology Council Life Sciences Tech 50 Awards Finalist, 2008
• University of Pittsburgh Entrepreneurial Fellowship Program, 2007
• American Physical Therapy Association’s (APTA) Finalist as Software Development Partner, 2003
• American Physical Therapy Association’s (APTA) Excellence in Home Care Award, 2002
• Duquesne University Distinguished Alumnus Award, 2000
• Inventor: System for Integrated Business Management: Ref No. 07-113 CIP (7911.0016)
US Patent Application No.: 12/235,190, Filed: September 22, 2008

Professional Activities & Memberships:
• Member of National Association for Home Care & Hospice (NAHC)
• Advisory Board Member, National Association of Home Care & Hospice (NAHC), 2009, 2010, 2011
• National Association for Home Care & Hospice (NAHC) Homecare and Hospice Industry Strategic Planning Congress, 2007, 2008, 2009
• National Association for Home Care & Hospice (NAHC) Proprietary Homecare Section
• National Association for Home Care & Hospice (NAHC) Therapy Advisory Committee
• Advisory Board Member, Institute of Entrepreneurial Excellence, University of Pittsburgh, Katz Graduate School of Business, 2011 & 2018
• Board of Directors of Duquesne University since 2010
• Duquesne University Century Club of Distinguished Alumni, September 2009
• Served on the Health Advisory Board for the 110th Congress member Jason Altmire, US House of Representatives, 4th District, PA
• Hospital Council of Western Pennsylvania Allied Member
• Active member of the American Physical Therapy Association (APTA) since 1992
• American Physical Therapy Association (APTA) Technology Special Interest Group, Government Federal Affairs Liaison, & Electronic
Communications/Telehealth Work Group
• Proprietary Home Care Association of America (PHCAA) Advisory Board Member, 2005
• Member of the Academic Advisory Board for Rangos School of Health Sciences (RSHS), Duquesne University
• Past President & Executive Board Member of the Duquesne University Alumni Association
• Homecare Elite Agency, 2009, 2010, 2011
• Company of the Year, Homecare Marketing Award, H2 Marketing, 2009

Specialties:
• Post-Acute Home & Community Healthcare Industry Strategic Planning / Home Healthcare Industry Business Development / Home Healthcare Industry Acquisitions, Startups and Joint Ventures / Home Healthcare Industry Information Technology

Mr. Mandato was one of the first investors in Vynca and joined the board in 2015. He leverages more than 25 years of experience as a successful CEO and company-builder to provide strategic guidance and mentorship in the areas of value creation, leadership and execution for Vynca’s management team.

Mr. Mandato is a Senior Advisor to Mainsail Partners and its portfolio companies. He has served as CEO of several successful operating companies, including two leveraged buyouts. The first, an ophthalmic implant company, was sold to a UK based public company, and the second, a leveraged purchase from Johnson & Johnson, subsequently acquired by a NYSE company. Both transactions resulted in significant value creation for shareholders. He also advised the founders, was an active investor and was appointed to the Board of Directors of Align Technology, Inc. (NASDAQ: ALGN), developer of the Invisalign clear orthodontic appliance.

Earlier in his career, he served as President and CEO of Origin Medsystems, a developer of minimally invasive surgical devices, where he also co-founded and served as CEO of Gynecare, a women’s health spin-out from Origin, which was later acquired by Johnson & Johnson. Origin was acquired by Guidant Corporation (NYSE; later acquired by Boston Scientific), where Mr. Mandato served as a Vice President and member of the founding management committee and CEO of two of its five operating units. He has served as an Entrepreneur-in-Residence at Mayfield Fund, a venture capital firm.

Prior to his distinguished career, Mr. Mandato served as a Captain in the U.S. Army. He currently serves on the boards of Embrace Global and has served on the board of Save the Children. He received his doctorate degree in management from Case Western Reserve University, and serves on its Board of Trustees. His research focused on the evolving role of boards in ensuring effective governance. He was appointed the 2014-2015 Carlo Rossi Chair of Entrepreneurship at The University of San Francisco’s School of Management and is a Lecturer at Stanford University. Additionally, he was a 2012 Fellow in the Harvard University Advanced Leadership Initiative.

Mr. Whitman is the founder and Chairman of Formation Capital, a leading equity investor in the seniors housing and care industry, and Co-Chairman of Genesis HealthCare. Most recently, he has become a partner in Aging2.0, a platform for innovation and technology for seniors. Over the past 15 years, Mr. Whitman has strategically led Formation Capital in its growth and execution of over $6 billion in transactions. Mr. Whitman serves on the board of Trident USA Health Services. He is also a current board member and Chairman Emeritus of the National Investment Center for Seniors Housing and Care Industries (NIC). His other interests in the “seniors” business include being a Principal in Primecare Properties, and a board member of Care Institute. Mr. Whitman’s career has allowed him extensive speaking engagements both domestically and internationally. He has written and been featured in many publications including National Real Estate Investor, McKnight’s Long Term Care News, SeniorCare Investor, Contemporary Long Term Care, Assisted Living Today, Modern Healthcare and Real Estate Forum.

Brad has spent over 20 years in the healthcare industry and has been investing in the space since 1999. During his investment career, Brad has been involved with 16 company boards of directors and the deployment of over $500 million in equity capital in the healthcare services and healthcare technology sectors. Prior to co-founding Questa, Brad was a senior investment professional at Parthenon Capital, a growth oriented private equity firm, where he helped lead their healthcare investment practice. During his time there, he deployed over $300 million in equity capital and served on eight different boards of directors. Prior to Parthenon, Brad worked at Broadlane, Inc., a healthcare technology company, where he was a member of the Executive Management Committee. Brad previously worked in a variety of healthcare investment roles at MTS Health Partners and Evercore Partners in their New York offices. Brad started his career in the Healthcare Investment Banking Group at Bear, Stearns & Co. Inc. in New York. Brad graduated from the University of North Carolina at Chapel Hill with a BA with distinction in Economics and concentration in Finance.

Aabed is a Partner at Questa Capital and has more than 15 years of investment and healthcare experience. Previously, he was a Director and member of the founding team at Martis Capital, where he focused on private equity investments in the healthcare sector. Prior to that, he was with Capricorn Investment Group, ExploraMed Development, and New Enterprise Associates. In these roles, he partnered with founders and management teams in the healthcare sector to develop new investment opportunities, structure creative investment solutions, and execute on strategic growth plans. Early in his career, Aabed contributed to the Human Genome Project, an international research effort funded by the National Institutes of Health. He also worked on health economics and policy matters at Kaiser Permanente and the U.K.’s National Health Service. Aabed graduated from Harvard University with an AB in Biochemical Sciences, and from Stanford University with an MD and MBA. He completed his residency training at Stanford University and continues to serve on the medical faculty as a Board-Certified Internal Medicine physician.